Recordati Industria Chimica e Farmaceutica Logo

Recordati Industria Chimica e Farmaceutica

A global pharmaceutical group that researches, develops, and markets medicines.

REC | XMIL

Overview

Corporate Details

ISIN(s):
IT0003828271 (+4 more)
LEI:
815600FBF92FD3531704
Country:
Italy
Address:
VIA MATTEO CIVITALI, 1, 20148 MILANO

Description

Recordati Industria Chimica e Farmaceutica is a global pharmaceutical group engaged in the research, development, manufacturing, and commercialization of medicines and pharmaceutical chemicals. The company's operations are structured across three main areas: specialty and primary care, rare diseases, and consumer healthcare. It provides a range of prescription and self-medication treatments for both common and rare conditions, with a core therapeutic focus that includes cardiovascular diseases. The group develops and markets treatment options for a wide spectrum of health needs, serving patients in approximately 150 countries.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-23 10:00
RECORDATI NOMINA MIKE MCCLELLAN NUOVO CHIEF FINANCIAL OFFICER
Italian 169.1 KB
2025-10-21 20:08
RECORDATI: Update on the execution of the share buy-back program
English 779.6 KB
2025-10-21 20:06
RECORDATI: Aggiornamento sull’esecuzione del programma di acquisto di azioni pr…
Italian 755.9 KB
2025-10-14 20:11
RECORDATI: Update on the execution of the share buy-back program
English 241.5 KB
2025-10-14 20:10
RECORDATI: Aggiornamento sull’esecuzione del programma di acquisto di azioni pr…
Italian 219.9 KB
2025-10-08 20:07
RECORDATI: Update on the execution of the share buy-back program
English 734.0 KB
2025-10-08 20:05
RECORDATI: Aggiornamento sull’esecuzione del programma di acquisto di azioni pr…
Italian 231.5 KB
2025-10-07 20:07
Allegato 3F
Italian 30.0 KB
2025-10-01 20:08
RECORDATI: Update on the execution of the share buy-back program
English 770.3 KB
2025-10-01 20:07
RECORDATI: Aggiornamento sull’esecuzione del programma di acquisto di azioni pr…
English 1016.9 KB
2025-09-23 20:05
RECORDATI: Update on the execution of the share buy-back program
English 611.2 KB
2025-09-23 20:04
RECORDATI: Aggiornamento sull’esecuzione del programma di acquisto di azioni pr…
English 907.3 KB
2025-09-18 20:04
RECORDATI ANNOUNCES RESIGNATION OF LUIGI LA CORTE AS GROUP CFO WHILE MAINTAININ…
English 172.7 KB
2025-09-18 20:02
RECORDATI COMUNICA LE DIMISSIONI DI LUIGI LA CORTE DAL RUOLO DI GROUP CFO, MANT…
Italian 158.3 KB
2025-09-17 20:07
RECORDATI: Update on the execution of the share buy-back program
English 813.4 KB

Automate Your Workflow. Get a real-time feed of all Recordati Industria Chimica e Farmaceutica filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Recordati Industria Chimica e Farmaceutica

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Recordati Industria Chimica e Farmaceutica via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Access Bio, Inc. Logo
Develops and manufactures in vitro diagnostic solutions for infectious diseases.
United States of America
950130
ACHIEVE LIFE SCIENCES, INC. Logo
A late-stage pharmaceutical company developing a treatment for nicotine dependence.
United States of America
ACHV
AC Immune SA Logo
Biopharmaceutical firm developing precision medicine for neurodegenerative diseases.
United States of America
ACIU
Aclaris Therapeutics, Inc. Logo
Clinical-stage biopharmaceutical company developing drugs for immuno-inflammatory diseases.
United States of America
ACRS
Acrivon Therapeutics, Inc. Logo
Clinical-stage biopharma using proteomics to develop precision oncology therapies.
United States of America
ACRV
Acticor Biotech Logo
Develops treatments for thrombotic diseases, focusing on acute ischemic stroke.
France
ALACT
Actinium Pharmaceuticals, Inc. Logo
Clinical-stage company developing targeted radiotherapies for difficult-to-treat cancers.
United States of America
ATNM
ACTUATE THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing therapies for cancers with high unmet needs.
United States of America
ACTU
AcuCort AB Logo
Develops user-friendly drug formulations for severe and acute allergic reactions.
Sweden
ACUC
Acumen Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing targeted therapies for Alzheimer's disease.
United States of America
ABOS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.